AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma. . Br J Dermatol 2024;190:e46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma. Br J Dermatol 2024;190:e46.
PMID: 38488655